Articles with "mcf adr" as a keyword



Novel Folate–Phenylfuran P‐gp Inhibitor Conjugates for Overcoming Multidrug Resistance in MCF‐7/ADR Cell

Sign Up to like & get
recommendations!
Published in 2025 at "ChemMedChem"

DOI: 10.1002/cmdc.202500216

Abstract: P‐glycoprotein (P‐gp) functions as a critical membrane transporter that drives tumor resistance by mediating drug efflux, ultimately contributing to multidrug resistance (MDR). Recently potent inhibitors have shown significant potential in countering chemotherapeutic resistance, particularly in… read more here.

Keywords: resistance; mcf adr; folate; cell ... See more keywords
Photo from archive.org

Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance

Sign Up to like & get
recommendations!
Published in 2019 at "Asian Journal of Pharmaceutical Sciences"

DOI: 10.1016/j.ajps.2018.06.006

Abstract: Mitochondria are currently known as novel targets for treating cancer, especially for tumors displaying multidrug resistance (MDR). This present study aimed to develop a mitochondria-targeted delivery system by using triphenylphosphonium cation (TPP+)-conjugated Brij 98 as… read more here.

Keywords: targeted ptx; mitochondria targeted; mcf; mcf adr ... See more keywords
Photo from wikipedia

Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell.

Sign Up to like & get
recommendations!
Published in 2021 at "European journal of medicinal chemistry"

DOI: 10.1016/j.ejmech.2021.113336

Abstract: P-glycoprotein (P-gp)-mediated multidrug resistance (MDR) is a phenomenon in which cells become resistant to structurally and mechanistically unrelated drugs resulting in low intracellular drug concentrations. It is one of the noteworthy problems in malignant tumor… read more here.

Keywords: mediated multidrug; reversal agents; mcf adr; glycoprotein mediated ... See more keywords
Photo from wikipedia

Development of oxoisoaporphine derivatives with topoisomerase I inhibition and reversal of multidrug resistance in breast cancer MCF-7/ADR cells.

Sign Up to like & get
recommendations!
Published in 2022 at "European journal of medicinal chemistry"

DOI: 10.1016/j.ejmech.2022.114300

Abstract: A series of oxoisoaporphine derivatives with topoisomerase I inhibition and cytotoxic activities. Among them, compound 14 showed the most potent cytotoxic activity against all cancer cell lines tested, and substantially lower cytotoxicity to LO2 cells.… read more here.

Keywords: adr cells; inhibition; cancer; mcf adr ... See more keywords

7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer.

Sign Up to like & get
recommendations!
Published in 2019 at "Life sciences"

DOI: 10.1016/j.lfs.2019.116938

Abstract: AIMS To investigate the effect of 7-O-geranylquercetin (GQ), a derivative of quercetin (Q), on reversing drug resistance in breast cancer MCF-7/ADR cells and reveal the mechanisms related to P-glycoprotein (P-gp). MAIN METHODS Cell viability was… read more here.

Keywords: drug resistance; mcf adr; adr cells; resistance ... See more keywords

Novel Hybrids of 3-Substituted Coumarin and Phenylsulfonylfuroxan as Potent Antitumor Agents with Collateral Sensitivity against MCF-7/ADR.

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of medicinal chemistry"

DOI: 10.1021/acs.jmedchem.2c00608

Abstract: Twenty-three new coumarin-furoxan hybrids were synthesized, which exhibited nanomole antiproliferation activities in A2780, A2780/CDDP, MCF-7/ADR, and MDA-MB-231. Among them, compound 9 showed the strongest collateral sensitivity to MCF-7/ADR with 499-fold potency compared with MCF-7. Notably,… read more here.

Keywords: mcf; compound; collateral sensitivity; mcf adr ... See more keywords

Design, synthesis and bioactivity study on oxygen-heterocyclic-based pyran analogues as effective P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell

Sign Up to like & get
recommendations!
Published in 2024 at "Scientific Reports"

DOI: 10.1038/s41598-024-56197-w

Abstract: P-glycoprotein (P-gp) imparts multi-drug resistance (MDR) on the cancers cell and malignant tumor clinical therapeutics. We report a class of newly designed and synthesized oxygen-heterocyclic-based pyran analogues (4a–l) bearing different aryl/hetaryl-substituted at the 1-postion were… read more here.

Keywords: adr cell; cell; mcf adr; oxygen heterocyclic ... See more keywords

Exploration of the inhibition action of TPGS on tumor cells and its combined use with chemotherapy drugs

Sign Up to like & get
recommendations!
Published in 2023 at "Drug Delivery"

DOI: 10.1080/10717544.2023.2183830

Abstract: Abstract D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) is a commonly used nonionic surfactant used as a pharmaceutical carrier in different drug delivery systems. TPGS can reverse P-glycoprotein (P-gp)-mediated multidrug resistance (MDR) and also has anticancer… read more here.

Keywords: tumor; tpgs; mcf adr; exploration inhibition ... See more keywords

Discovery of benzochromene derivatives first example with dual cytotoxic activity against the resistant cancer cell MCF-7/ADR and inhibitory effect of the P-glycoprotein expression levels

Sign Up to like & get
recommendations!
Published in 2023 at "Journal of Enzyme Inhibition and Medicinal Chemistry"

DOI: 10.1080/14756366.2022.2155814

Abstract: Abstract A series of 1H-benzo[f]chromene moieties (4a–z) were synthesised under Ultrasonic irradiation and confirmed with spectral analyses. Derivative 4i solely possessed an X-ray single crystal. The anti-proliferative efficacy of the desired molecules has been explored… read more here.

Keywords: cancer; mcf adr; glycoprotein expression; expression ... See more keywords

Microribonucleic Acid-15a-5p Alters Adriamycin Resistance in Breast Cancer Cells by Targeting Cell Division Cycle-Associated Protein 4

Sign Up to like & get
recommendations!
Published in 2021 at "Cancer Management and Research"

DOI: 10.2147/cmar.s333830

Abstract: Objective Although chemotherapy is one of the first line clinical treatment of tumors, the efficacy of chemotherapy has been severely restricted by the frequent occurrence of drug resistance phenomenon. Multiple studies found that miRNAs can… read more here.

Keywords: cycle; adriamycin resistance; cell; mcf adr ... See more keywords

Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers

Sign Up to like & get
recommendations!
Published in 2018 at "International Journal of Nanomedicine"

DOI: 10.2147/ijn.s157368

Abstract: Background Multidrug resistance (MDR) is one of the major obstacles to successful cancer chemotherapy. Developing efficient strategies to reverse MDR remains a major challenge. Surfactin (SUR), a cyclic lipopeptide biosurfactant, has been found to display… read more here.

Keywords: sur nanoparticles; mcf adr; dox; multidrug resistance ... See more keywords